DEXCOM INC's ticker is and the CUSIP is 252131AH0. A total of 33 filers reported holding DEXCOM INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $14,123,687 | +11.5% | 4,529,000 | +1.1% | 0.00% | – |
| Q1 2023 | $12,662,133 | -37.5% | 4,479,000 | -39.1% | 0.00% | -100.0% |
| Q4 2022 | $20,252,916 | +51.2% | 7,354,000 | +8.9% | 0.00% | – |
| Q3 2022 | $13,397,000 | -3.2% | 6,754,000 | -10.3% | 0.00% | – |
| Q2 2022 | $13,838,000 | -14.9% | 7,529,000 | +44.0% | 0.00% | – |
| Q1 2022 | $16,269,000 | -3.3% | 5,229,000 | +1.5% | 0.00% | – |
| Q4 2021 | $16,831,000 | -8.4% | 5,154,000 | -6.8% | 0.00% | -100.0% |
| Q3 2021 | $18,380,000 | +39.3% | 5,529,000 | +8.9% | 0.00% | – |
| Q2 2021 | $13,199,000 | +27.7% | 5,079,000 | +8.3% | 0.00% | – |
| Q1 2021 | $10,333,000 | +22.7% | 4,689,000 | +26.6% | 0.00% | – |
| Q4 2020 | $8,424,000 | +22.4% | 3,705,000 | +36.0% | 0.00% | – |
| Q3 2020 | $6,884,000 | +1.8% | 2,725,000 | 0.0% | 0.00% | – |
| Q2 2020 | $6,760,000 | +11.3% | 2,725,000 | -21.6% | 0.00% | – |
| Q1 2020 | $6,075,000 | +36.7% | 3,475,000 | +15.8% | 0.00% | – |
| Q4 2019 | $4,444,000 | – | 3,000,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Elequin Capital, LP | 11,771,000 | $26,632,270 | 5.17% |
| Calamos Advisors LLC | 30,006,000 | $67,881,974 | 0.35% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 5,000,000 | $11,302,500 | 0.05% |
| D. E. Shaw & Co., Inc. | 10,000,000 | $23,351,070 | 0.02% |
| UBS ASSET MANAGEMENT AMERICAS LLC | 23,000,000 | $52,692,310 | 0.02% |
| BNP PARIBAS FINANCIAL MARKETS | 1,035,000 | $2,337,030 | 0.00% |
| LOOMIS SAYLES & CO L P | 9,739 | $909 | 0.00% |
| MORGAN STANLEY | 2,500,000 | $5,648,750 | 0.00% |
| FMR LLC | 6,019,000 | $13,590,902 | 0.00% |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 200,000 | $451,600 | 0.00% |